Medication Integration in Treatment of Comorbid Adolescent Substance Users/Attention Deficit Hyperactivity Disorder
Completed · Phase 1
Conditions studied: Attention Deficit Hyperactivity Disorder, Attention Deficit Disorder
In brief
The goal of this project is to develop and test a brief protocol designed to systematically integrate pharmacological interventions for Attention Deficit Hyperactivity Disorder (ADHD) into behavioral treatment services for adolescent substance users with co-morbid ADHD in everyday care. Primary study aims will yield proof-of-concept data on MIP feasibility and fidelity in usual care and evidence of MIP impact on psychiatric and behavioral services utilization, medication acceptance and compliance, and satisfaction with treatment services.
Key facts
- Study ID
- NCT01369459
- Run by
- The National Center on Addiction and Substance Abuse at Columbia University
- People needed
- 14
- Starts
- 2011-11-01
- Expected to finish
- 2014-12-01
- Last updated by the study team
- 2015-08-05
Who can join
Age: 13 and older, up to 17. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age 13-17 years
- Caregiver able to participate in treatment
- One day of alcohol use to intoxication or illegal drug use in the past 30 days (or 30 days prior to living in a controlled environment)
- endorsement of one or more DSM-IV symptoms of Substance Use or Alcohol Dependence/Abuse
- meet ASAM criteria for outpatient substance use treatment
- meet DSM-IV criteria for ADHD (with or without onset prior to age 7)
- not enrolled in any behavioral treatment
You may not qualify if…
- MDD
- Bipolar Disorder
- Mental Retardation
- PDD
- medical or psychiatric illness requiring hospitalization
- current psychotic features
- currently suicidal
Where it is running
- Roberto Clemente Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.